Mary Rinella to Injections, Subcutaneous
This is a "connection" page, showing publications Mary Rinella has written about Injections, Subcutaneous.
Connection Strength
0.113
-
Efruxifermin in Compensated Liver Cirrhosis Caused by MASH. N Engl J Med. 2025 Jun 26; 392(24):2413-2424.
Score: 0.056
-
Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis. N Engl J Med. 2025 Jun 05; 392(21):2089-2099.
Score: 0.056